LINC01906

Across TCGA pan-cancer cohorts, LINC01906 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated LINC01906 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher LINC01906 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC01906 expression acts as an unfavorable survival marker, although some lineages such as BRCA show a favorable association.

UVM, THCA, and BRCA are the cancer types where LINC01906 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	DFS	Tertile	II,III,IV	0.288	0.708	<.001	98	view →
THCA	OS	Tertile	III,IV	0.133	0.922	<.001	60	view →
BRCA	OS	Median	II,III,IV	0.977	0.943	.002	49	view →
COAD	DFS	Tertile	III,IV	0.130	0.616	.006	45	view →
KIRC	DFS	Tertile	II,III,IV	0.253	0.766	.003	36	view →
LIHC	OS	Tertile	All	0.083	0.783	<.001	36	view →
BLCA	OS	Tertile	All	0.161	0.616	.039	18	view →
LAML	DFS	Tertile	All	0.140	0.582	.020	18	view →
SKCM	DFS	Tertile	IV	0.036	0.433	<.001	9	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →
LGG	DFS	Tertile	All	0.214	0.756	<.001	9	view →
UCEC	DFS	Tertile	All	0.777	0.899	.046	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

LINC01906–UVM (DFS)

Open the UVM breakdown →